Shunqiang Li

Washington University in St. Louis

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.326Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis

Cancer Research(2024)10.1158/0008-5472.can-23-1349

Top 62%

0.222DataRank

Top 62%3 citations

Xing Yi Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +49 more

Papers

Driven by 52 papers — median percentile 0. Top paper: “Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy”.

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

Cell(2020)10.1016/j.cell.2020.10.036

N/A

8.1DataRank · unranked

565 citations

Eric J. Jaehnig, Shankha Satpathy, Lili M. Blumenberg, Alla Y. Karpova, Meenakshi Anurag +85 more

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Nature Communications(2017)10.1038/ncomms14864

N/A

4.9DataRank · unranked

155 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0200

N/A

2.5DataRank · unranked

140 citations

Eric J. Jaehnig, Karsten Krug, Jonathan T. Lei, Erik J. Bergstrom, Beom-Jun Kim +34 more

Breast tumors educate the proteome of stromal tissue in an individualized but coordinated manner

Science Signaling(2017)10.1126/scisignal.aam8065

N/A

1.2DataRank · unranked

24 citations

Arshag D. Mooradian, Petra Erdmann-Gilmore, Qiang Zhang, Rosa Viner, Sherri R. Davies +12 more

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer

Nature Communications(2021)10.1038/s41467-021-23271-0

N/A

0.995DataRank · unranked

23 citations

Sinem Şeker, Vaishnavi Devarakonda, Aloran Mazumder, Rashi Kalra, Ching Hui Chen +6 more

Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Nature Communications(2017)10.1038/ncomms15479

N/A

0.843DataRank · unranked

11 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach

iScience(2022)10.1016/j.isci.2022.105799

N/A

0.830DataRank · unranked

35 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram Srinivasan +25 more

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Nature Genetics(2021)10.1038/s41588-020-00750-6

N/A

0.790DataRank · unranked

193 citations

Jessica Giordano, Anuj Srivastava, Min Jin Ha, Michael W. Lloyd, Roebi de Bruijn +57 more

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

UNC Libraries(2020)10.17615/0xdg-yq72

N/A

0.552DataRank · unranked

6 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer

Nature Communications(2024)10.1038/s41467-024-49875-w

N/A

0.524DataRank · unranked

32 citations

Shuyan Zhou, Yan Kai, Ya-qin Zhang, Changmin Peng, Zhuqing Li +10 more

Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models

Cancers(2020)10.3390/cancers12123857

N/A

0.396DataRank · unranked

13 citations

Tina Primeau, Jingqin Luo, Cynthia Zhang, Hua Sun, Jeremy Hoog +10 more

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis

Cancer Research(2024)10.1158/0008-5472.can-23-1349

Top 62%

0.222DataRank

Top 62%3 citations

Xing Yi Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +49 more

Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0047

N/A

0.208DataRank · unranked

3 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nikki Fettig +11 more

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

UNC Libraries(2020)10.17615/rdzv-r921

Top 78%

0.104DataRank

Top 78%1 citations

Richard D. Smith, Robbert J.C. Slebos, Shisheng Sun, Zhen Zhang, Hui Zhang +33 more

Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416134.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Hyaluronan-Conjugated Carbon Quantum Dots for Bioimaging Use

ACS Applied Materials & Interfaces(2020)10.1021/acsami.0c20088

N/A

0DataRank · unranked

129 citations

Amine M. Laradji, Tina Primeau, Mikhail Y. Berezin, Shunqiang Li, Nathan Ravi +1 more

Optimal co-clinical radiomics: Sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging

EBioMedicine(2020)10.1016/j.ebiom.2020.102963

N/A

0DataRank · unranked

114 citations

Timothy Whitehead, James D. Quirk, Amber Salter, Foluso O. Ademuyiwa, Shunqiang Li +3 more

Selective imaging of solid tumours via the calcium-dependent high-affinity binding of a cyclic octapeptide to phosphorylated Annexin A2

Nature Biomedical Engineering(2020)10.1038/s41551-020-0528-7

N/A

0DataRank · unranked

49 citations

Baogang Xu, Kexian Liang, Rui Tang, Gail Sudlow, Christopher Egbulefu +16 more

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models

UNC Libraries(2020)10.17615/zy2g-ye61

N/A

0DataRank · unranked

19 citations

Christine E. Ryan, Aleix Prat, Zhanfang Guo, Matthew J. Ellis, W. Timothy Schaiff +8 more

RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer

British Journal of Cancer(2020)10.1038/s41416-020-01174-z

N/A

0DataRank · unranked

27 citations

Guowei Gu, Amanda Beyer, Sarah K. Herzog, David G. Edwards, Hangqing Lin +12 more

QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues

UNC Libraries(2020)10.17615/gcj3-5y88

N/A

0DataRank · unranked

0 citations

John A. Wrobel, Shunqiang Li, Ling Xie, Sherri R. Davies, Harsha P. Gunawardena +4 more

Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer

Cancer Research(2021)10.1158/0008-5472.can-21-1256

N/A

0DataRank · unranked

24 citations

Meenakshi Anurag, Jonathan T. Lei, Beom‐Jun Kim, Purba Singh, Sinem Şeker +16 more

Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2961

N/A

0DataRank · unranked

12 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jin-Ah Kim +13 more

A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.20.457116

N/A

0DataRank · unranked

5 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram +19 more

Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin

Molecular & Cellular Proteomics(2022)10.1016/j.mcpro.2022.100476

N/A

0DataRank · unranked

23 citations

Petra Erdmann-Gilmore, Jacqueline L. Mudd, Qiang Zhang, R. W. Seymour, Zhanfang Guo +11 more

Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102700

N/A

0DataRank · unranked

11 citations

Haibo Xie, Miyang Li, Ang Gao, M Ma, Yidan Wang +8 more

A pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.26.512745

Top 100%

0DataRank

Top 100%0 citations

X. Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +45 more

Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.09.515796

N/A

0DataRank · unranked

0 citations

Yirui Sun, Maureen Highkin, Nagalaxmi Vemalapally, Xiaohua Jin, Brandon Zhou +9 more

Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

Cancer Research(2023)10.1158/0008-5472.can-22-3558

N/A

0DataRank · unranked

33 citations

Yirui Sun, Maureen Highkin, Nagalaxmi Vemalapally, Xiaohua Jin, Brandon Zhou +9 more

Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting

PLoS ONE(2023)10.1371/journal.pone.0293700

N/A

0DataRank · unranked

24 citations

Alison K. Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su, John S. Allen +13 more

Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials

Tomography(2023)10.3390/tomography9020053

N/A

0DataRank · unranked

11 citations

Cristian T. Badea, Thomas L. Chenevert, Heike E. Daldrup‐Link, Li Ding, Lacey E. Dobrolecki +20 more

Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-22-3484

N/A

0DataRank · unranked

12 citations

Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt +11 more

Neratinib Synergizes with Trastuzumab Antibody Drug Conjugate or with Vinorelbine to Treat HER2 Mutated Breast Cancer Patient Derived Xenografts and Organoids

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.19.572069

N/A

0DataRank · unranked

2 citations

Tina Primeau, Maureen Highkin, Stephanie L. Pratt, Ashley R. Tipton, Nagalaxmi Vemalapally +9 more

Data from Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

(2023)10.1158/1078-0432.c.6531045

N/A

0DataRank · unranked

0 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jinah Kim +13 more

Data from WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells

(2023)10.1158/1535-7163.c.6531509.v1

N/A

0DataRank · unranked

0 citations

Anne R. Simoneau, Wu-xiang Liao, Yi Guo, Christopher M. Hope, Feng Liu +8 more

Data from WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells

(2023)10.1158/1535-7163.c.6531509

N/A

0DataRank · unranked

0 citations

Anne R. Simoneau, Wu-xiang Liao, Yi Guo, Christopher M. Hope, Feng Liu +8 more

O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer

Research Square(2023)10.21203/rs.3.rs-3377962/v1

N/A

0DataRank · unranked

0 citations

Yi Zhang, Shuyan Zhou, Kai Yan, Yaqin Zhang, Changmin Peng +8 more

Supplementary File 5 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416119.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB–Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer

Cancer Research(2025)10.1158/0008-5472.can-24-2492

N/A

0DataRank · unranked

6 citations

Yi Zhang, Julie Belmar, Chunyan Hou, Yaqin Zhang, Changmin Peng +12 more

Supplementary File 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416128.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416122

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416116

Top 100%

0DataRank

Top 100%0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.c.6509465.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416134

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 1 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416131.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 5 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416119

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416116.v1

Top 100%

0DataRank

Top 100%0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.c.6509465

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Extended Methods from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416140

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416128

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416122.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Extended Methods from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416140.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Shunqiang Li

Indexed papers

Top data-sharing exemplar

Papers